KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Other Non-Current Assets (2020 - 2025)

Oscar Health's Other Non-Current Assets history spans 6 years, with the latest figure at $119.7 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 45.3% year-over-year to $119.7 million; the TTM value through Dec 2025 reached $119.7 million, up 45.3%, while the annual FY2025 figure was $119.7 million, 45.3% up from the prior year.
  • Other Non-Current Assets reached $119.7 million in Q4 2025 per OSCR's latest filing, down from $120.6 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $120.6 million in Q3 2025 to a low of $18.8 million in Q3 2021.
  • Average Other Non-Current Assets over 5 years is $84.6 million, with a median of $93.0 million recorded in 2023.
  • Peak YoY movement for Other Non-Current Assets: skyrocketed 635.02% in 2021, then fell 12.12% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $96.6 million in 2021, then decreased by 1.86% to $94.8 million in 2022, then dropped by 12.12% to $83.3 million in 2023, then dropped by 1.05% to $82.4 million in 2024, then soared by 45.3% to $119.7 million in 2025.
  • Per Business Quant, the three most recent readings for OSCR's Other Non-Current Assets are $119.7 million (Q4 2025), $120.6 million (Q3 2025), and $116.3 million (Q2 2025).